Patent application number | Description | Published |
20080246286 | PIEZO ACTUATED SLIDE LATCHING MECHANISM - A latching mechanism is particularly suited for use in latching a slide mechanism, such as used to slidably mount a drawer. The latching mechanism includes a latch assembly comprising a latch lever mounted for movement between a first, second and third positions, a latch tab for selective engagement with a second end of the latch lever, and a piezo electric controller. The controller has a plunger configured to selectively control the movement of the latch lever between the first and second positions, the plunger movable between an extended position corresponding to a first, locked position of the latch lever and a retracted position corresponding to the second, unlocked position of the latch lever, the controller when unpowered preventing the plunger from moving from the extended to the retracted position and the controller when powered permitting the plunger to move from the extended to the retracted position. | 10-09-2008 |
20110012374 | PIEZO ACTUATED SLIDE LATCHING MECHANISM - A latching mechanism is particularly suited for use in latching a slide mechanism, such as used to slidably mount a drawer. The latching mechanism includes a latch assembly comprising a latch lever mounted for movement between a first, second and third positions, a latch tab for selective engagement with a second end of the latch lever, and a piezo electric controller. The controller has a plunger configured to selectively control the movement of the latch lever between the first and second positions, the plunger movable between an extended position corresponding to a first, locked position of the latch lever and a retracted position corresponding to the second, unlocked position of the latch lever, the controller when unpowered preventing the plunger from moving from the extended to the retracted position and the controller when powered permitting the plunger to move from the extended to the retracted position. | 01-20-2011 |
Patent application number | Description | Published |
20110293725 | CHIMERIC THERAPEUTICS, COMPOSITIONS, AND METHODS FOR USING SAME - Chimeric therapeutics are disclosed that include a modified viral core protein and a nucleic acid bound to the modified viral core protein. The nucleic acid may be substantially homologous to a specific gene target. In some embodiments, the nucleic acid bound to the modified viral core protein is substantially non-immunogenic. Also disclosed are particles and compositions that include disclosec chimeric therapeutics. | 12-01-2011 |
20110293726 | CHIMERIC THERAPEUTICS, COMPOSITIONS, AND METHODS FOR USING SAME - Chimeric therapeutics are disclosed that include a modified viral core protein and a nucleic acid bound to the modified viral core protein. The nucleic acid may be substantially homologous to a specific gene target. In some embodiments, the nucleic acid bound to the modified viral core protein is substantially non-immunogenic. Also disclosed are particles and compositions that include disclosed chimeric therapeutics. | 12-01-2011 |
20110293727 | CHIMERIC THERAPEUTICS, COMPOSITIONS, AND METHODS FOR USING SAME - Chimeric therapeutics are disclosed that include a modified viral core protein and a nucleic acid bound to the modified viral core protein. The nucleic acid may be substantially homologous to a specific gene target. In some embodiments, the nucleic acid bound to the modified viral core protein is substantially non-immunogenic. Also disclosed are particles and compositions that include disclosec chimeric therapeutics. | 12-01-2011 |
20130156818 | METHODS AND COMPOSITIONS FOR CONTROLLING ASSEMBLY OF VIRAL PROTEINS - Provided herein are methods and compositions for controlling assembly of modified viral core proteins, for example, into a viral capsid or a nanocage. In some embodiments, the disclosed modified viral core proteins comprise at least one mutation or modification that can substantially prevent assembly of the viral core proteins until assembly is desired. In some embodiments, assembly of the viral core proteins may be triggered, for example, by contacting the viral core proteins with a reducing agent and/or by reducing the concentration of a denaturant. The viral core proteins may self-assemble to form a viral capsid or nanocage. | 06-20-2013 |
20140010885 | SELF-ASSEMBLING NANOPARTICLE DRUG DELIVERY SYSTEM - A self-assembling nanoparticle drug delivery system for the delivery of various bioactive agents including peptides, proteins, nucleic acids or synthetic chemical drugs is provided. The self-assembling nanoparticle drug delivery system described herein includes viral capsid proteins, such as Hepatitis B Virus core protein, encapsulating the bioactive agent, a lipid layer or lipid/cholesterol layer coat and targeting or facilitating molecules anchored in the lipid layer. A method for construction of the self-assembling nanoparticle drug delivery system is also provided. | 01-09-2014 |
Patent application number | Description | Published |
20110139176 | LOW DAMAGE PHOTORESIST STRIP METHOD FOR LOW-K DIELECTRICS - Improved methods for stripping photoresist and removing etch-related residues from dielectric materials are provided. In one aspect of the invention, methods involve removing material from a dielectric layer using a hydrogen-based etch process employing a weak oxidizing agent and fluorine-containing compound. Substrate temperature is maintained at a level of about 160° C. or less, e.g., less than about 90° C. | 06-16-2011 |
20110143548 | ULTRA LOW SILICON LOSS HIGH DOSE IMPLANT STRIP - Improved methods for stripping photoresist and removing ion implant related residues from a work piece surface are provided. According to various embodiments, plasma is generated using elemental hydrogen, a fluorine-containing gas and a protectant gas. The plasma-activated gases reacts with the high-dose implant resist, removing both the crust and bulk resist layers, while simultaneously protecting exposed portions of the work piece surface. The work piece surface is substantially residue free with low silicon loss. | 06-16-2011 |
20130048014 | PHOTORESIST STRIP PROCESSES FOR IMPROVED DEVICE INTEGRITY - Provided herein are methods and apparatus of hydrogen-based photoresist strip operations that reduce dislocations in a silicon wafer or other substrate. According to various embodiments, the hydrogen-based photoresist strip methods can employ one or more of the following techniques: 1) minimization of hydrogen budget by using short processes with minimal overstrip duration, 2) providing dilute hydrogen, e.g., 2%-16% hydrogen concentration, 3) minimization of material loss by controlling process conditions and chemistry, 4) using a low temperature resist strip, 5) controlling implant conditions and concentrations, and 6) performing one or more post-strip venting processes. Apparatus suitable to perform the photoresist strip methods are also provided. | 02-28-2013 |
20140120733 | LOW DAMAGE PHOTORESIST STRIP METHOD FOR LOW-K DIELECTRICS - Improved methods for stripping photoresist and removing etch-related residues from dielectric materials are provided. In one aspect of the invention, methods involve removing material from a dielectric layer using a hydrogen-based etch process employing a weak oxidizing agent and fluorine-containing compound. Substrate temperature is maintained at a level of about 160° C. or less, e.g., less than about 90° C. | 05-01-2014 |
Patent application number | Description | Published |
20080221412 | Method and apparatus for spectroscopic tissue analyte measurement - Methods and systems for calculating body fluid metrics are provided. In accordance with an exemplary embodiment of the present technique, there is provided a method for calculating body fluid metrics by acquiring an absorbance spectrum of a subject's tissue over a range of near-infrared light, performing a multi-linear regression of the absorbance spectrum of the subject's tissue in relation to absorbance spectra of tissue constituents, and calculating body fluid metrics based on the results of the multi-linear regression. A system is provided having a sensor for emitting the light into the subject's tissue and detecting reflected, scattered, or transmitted light, a spectrometer for processing the detected light and generating the absorbance spectrum of the subject's tissue, memory for storing absorbance spectra of the tissue constituents and a multi-linear regression model, and a processor for performing the multi-linear regression and calculating the body fluid metrics. | 09-11-2008 |
20090165801 | CARBON DIOXIDE DETECTOR HAVING AN ACRYLIC BASED SUBSTRATE - Embodiments disclosed herein may include a carbon dioxide detector having an acrylic-based substrate impregnated with a carbon dioxide sensitive dye. The carbon dioxide sensitive dye may include a pH indicator which changes color based on the concentration of carbon dioxide in the air at the surface of the indicator. In some embodiments, the impregnated polymer may be incorporated into a window in the carbon dioxide detector, while in other embodiments an element of a ventilation system may be composed of the impregnated polymer. For example, a casing for an endotracheal tube or the tube itself may be composed of the acrylic-based polymer impregnated with the carbon dioxide sensitive dye. | 07-02-2009 |
20090216096 | METHOD AND APPARATUS TO DETERMINE SKIN STEROL LEVELS - A method and apparatus is provided for measuring a sterol, such as cholesterol, deposited in the skin. Light of two or more wavelengths is emitted toward or into a skin sample and the light is differentially absorbed by the sterol in the skin sample. The differentially absorbed light is detected and the amount of sterol in the skin sample is determined based on the differential absorption. | 08-27-2009 |
20110046464 | PHOTOPLETHYSMOGRAPHY WITH CONTROLLED APPLICATION OF SENSOR PRESSURE - Systems, methods, and devices for obtaining consistently reproducible diagnostic measurements with a photoplethysmographic sensor are provided. In one embodiment, a method for obtaining such a diagnostic measurement includes applying a pressure between a photoplethysmographic sensor and a patient, increasing the pressure until the photoplethysmographic sensor outputs a plethysmographic waveform of minimal amplitude, decreasing the pressure by a predetermined fraction, and obtaining a diagnostic measurement using the photoplethysmographic sensor. The pressure may be applied using a pressure device that includes, for example, a clip, a wrap, an inflatable balloon or bladder, or an inflatable cuff or any combination thereof. | 02-24-2011 |
20130261487 | CARBON DIOXIDE-SENSING AIRWAY PRODUCTS AND TECHNIQUE FOR USING THE SAME - An airway device is provided that may track the flow of respiratory gases through the device with sensing elements at a plurality of locations along the gas flow path of the device. Such a device may be useful for assessing a variety of clinical states, for adjusting patient ventilator settings, or for determining whether or not an airway device has been properly inserted into a patient airway. | 10-03-2013 |
20130289371 | PHOTOPLETHYSMOGRAPHY WITH CONTROLLED APPLICATION OF SENSOR PRESSURE - Systems, methods, and devices for obtaining consistently reproducible diagnostic measurements with a photoplethysmographic sensor are provided. In one embodiment, a method for obtaining such a diagnostic measurement includes applying a pressure between a photoplethysmographic sensor and a patient, increasing the pressure until the photoplethysmographic sensor outputs a plethysmographic waveform of minimal amplitude, decreasing the pressure by a predetermined fraction, and obtaining a diagnostic measurement using the photoplethysmographic sensor. The pressure may be applied using a pressure device that includes, for example, a clip, a wrap, an inflatable balloon or bladder, or an inflatable cuff, or any combination thereof. | 10-31-2013 |